Summary:
- This article discusses a promising new treatment for lung cancer that targets the HER2 protein, which is often found in certain types of lung cancer.
- The treatment, called trastuzumab deruxtecan, has shown promising results in clinical trials for patients with lung cancer who have already been treated with other therapies.
- The treatment works by delivering a chemotherapy drug directly to cancer cells that have the HER2 protein, which can help kill the cancer cells while minimizing side effects for the patient.